AHRQ seeks evidence to inform review of telehealth use during pandemic
The Agency for Healthcare Research and Quality through Nov. 12 on scientific evidence to inform a systematic review of telehealth use during COVID-19. Topics include the characteristics of patients and providers using telehealth and how they differ from before the pandemic; benefits and potential harms of telehealth use; successful telehealth strategies; and cost and reimbursement considerations. For more on the study by AHRQ’s Evidence-based Practice Centers Program, .
Related News Articles
Headline
A bipartisan group of 60 senators April 2 reintroduced the CONNECT for Health Act, AHA-supported legislation that would expand patient access to telehealth…
Headline
Today the Drug Enforcement Administration and Department of Health and Human Services announced that the effective date for the final rule regarding…
Headline
The Department of Health and Human Services and Drug Enforcement Administration published a series of rules Jan. 15 related to telemedicine prescribing of…
Headline
The Department of Health and Human Services Health Sector Cybersecurity Coordination Center Jan. 8 released guidance on cybersecurity for telehealth…
Headline
The Drug Enforcement Administration and Department of Health and Human Services Nov. 15 issued a final rule extending certain telemedicine prescribing…
Headline
In comments Nov. 12 to majority and minority leaders of the House and Senate, the AHA requested that Congress act on key priorities for hospitals and health…